http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 25 Nov 2024 09:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Revolutionizes+ESG+with+HemoHIM%2C+an+Eco-friendly+Health+Supplement/24026756.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54157497&amp;newsitemid=20241125344450&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=5eacae4c0dc4416dc535a66e4dbbf1b8" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is at the forefront of Environmental, Social, and Governance (ESG) management through eco-conscious research and development (R&amp;D). </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241125344450/en/" rel="nofollow">https://www.businesswire.com/news/home/20241125344450/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241125344450/en/2315060/4/Photo._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> The company is dedicated to investing in eco-friendly http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Revolutionizes+ESG+with+HemoHIM%2C+an+Eco-friendly+Health+Supplement/24026756.html Mon, 25 Nov 2024 09:00:00 -0500 200130 O.18769681 http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Revolutionizes+ESG+with+HemoHIM%2C+an+Eco-friendly+Health+Supplement/24026756.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54157497&amp;newsitemid=20241125344450&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=5eacae4c0dc4416dc535a66e4dbbf1b8" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is at the forefront of Environmental, Social, and Governance (ESG) management through eco-conscious research and development (R&amp;D). </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241125344450/en/" rel="nofollow">https://www.businesswire.com/news/home/20241125344450/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241125344450/en/2315060/4/Photo._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> The company is dedicated to investing in eco-friendly http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Revolutionizes+ESG+with+HemoHIM%2C+an+Eco-friendly+Health+Supplement/24026756.html Mon, 25 Nov 2024 09:00:00 -0500 200130 O.18769681 http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Revolutionizes+ESG+with+HemoHIM%2C+an+Eco-friendly+Health+Supplement/24026756.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54157497&amp;newsitemid=20241125344450&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=5eacae4c0dc4416dc535a66e4dbbf1b8" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is at the forefront of Environmental, Social, and Governance (ESG) management through eco-conscious research and development (R&amp;D). </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241125344450/en/" rel="nofollow">https://www.businesswire.com/news/home/20241125344450/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241125344450/en/2315060/4/Photo._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> The company is dedicated to investing in eco-friendly http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Revolutionizes+ESG+with+HemoHIM%2C+an+Eco-friendly+Health+Supplement/24026756.html Mon, 25 Nov 2024 09:00:00 -0500 200130 O.18769681 http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Revolutionizes+ESG+with+HemoHIM%2C+an+Eco-friendly+Health+Supplement/24026756.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54157497&amp;newsitemid=20241125344450&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=5eacae4c0dc4416dc535a66e4dbbf1b8" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is at the forefront of Environmental, Social, and Governance (ESG) management through eco-conscious research and development (R&amp;D). </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241125344450/en/" rel="nofollow">https://www.businesswire.com/news/home/20241125344450/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241125344450/en/2315060/4/Photo._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> The company is dedicated to investing in eco-friendly http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Revolutionizes+ESG+with+HemoHIM%2C+an+Eco-friendly+Health+Supplement/24026756.html Mon, 25 Nov 2024 09:00:00 -0500 200130 O.18769681 http://www.streetinsider.com/Press+Releases/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- ‘HemoHim,’ an immune-boosting health supplement from <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54138541&amp;newsitemid=20241021625609&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=9b155d49752d5f05f5c309c911f60720" shape="rect">Kolmar BNH</a> (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241021625609/en/" rel="nofollow">https://www.businesswire.com/news/home/20241021625609/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241021625609/en/2278151/4/Pic._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)</p></div><p> Kolmar http://www.streetinsider.com/Press+Releases/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html Mon, 21 Oct 2024 09:00:00 -0500 200130 A.06822034 O.18769681 O.20026344 http://www.streetinsider.com/Press+Releases/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- ‘HemoHim,’ an immune-boosting health supplement from <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54138541&amp;newsitemid=20241021625609&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=9b155d49752d5f05f5c309c911f60720" shape="rect">Kolmar BNH</a> (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241021625609/en/" rel="nofollow">https://www.businesswire.com/news/home/20241021625609/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241021625609/en/2278151/4/Pic._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)</p></div><p> Kolmar http://www.streetinsider.com/Press+Releases/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html Mon, 21 Oct 2024 09:00:00 -0500 200130 A.06822034 O.18769681 O.20026344 http://www.streetinsider.com/Press+Releases/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- ‘HemoHim,’ an immune-boosting health supplement from <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54138541&amp;newsitemid=20241021625609&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=9b155d49752d5f05f5c309c911f60720" shape="rect">Kolmar BNH</a> (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241021625609/en/" rel="nofollow">https://www.businesswire.com/news/home/20241021625609/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241021625609/en/2278151/4/Pic._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)</p></div><p> Kolmar http://www.streetinsider.com/Press+Releases/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html Mon, 21 Oct 2024 09:00:00 -0500 200130 A.06822034 O.18769681 O.20026344 http://www.streetinsider.com/Press+Releases/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- ‘HemoHim,’ an immune-boosting health supplement from <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54138541&amp;newsitemid=20241021625609&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=9b155d49752d5f05f5c309c911f60720" shape="rect">Kolmar BNH</a> (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241021625609/en/" rel="nofollow">https://www.businesswire.com/news/home/20241021625609/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241021625609/en/2278151/4/Pic._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)</p></div><p> Kolmar http://www.streetinsider.com/Press+Releases/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html Mon, 21 Oct 2024 09:00:00 -0500 200130 A.06822034 O.18769681 O.20026344 http://www.streetinsider.com/Business+Wire/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- ‘HemoHim,’ an immune-boosting health supplement from <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54138541&amp;newsitemid=20241021625609&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=9b155d49752d5f05f5c309c911f60720" shape="rect">Kolmar BNH</a> (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241021625609/en/" rel="nofollow">https://www.businesswire.com/news/home/20241021625609/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241021625609/en/2278151/4/Pic._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)</p></div><p> Kolmar http://www.streetinsider.com/Business+Wire/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html Mon, 21 Oct 2024 09:00:00 -0500 200130 A.06822034 O.18769681 O.20026344 http://www.streetinsider.com/Business+Wire/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- ‘HemoHim,’ an immune-boosting health supplement from <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54138541&amp;newsitemid=20241021625609&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=9b155d49752d5f05f5c309c911f60720" shape="rect">Kolmar BNH</a> (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241021625609/en/" rel="nofollow">https://www.businesswire.com/news/home/20241021625609/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241021625609/en/2278151/4/Pic._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)</p></div><p> Kolmar http://www.streetinsider.com/Business+Wire/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html Mon, 21 Oct 2024 09:00:00 -0500 200130 A.06822034 O.18769681 O.20026344 http://www.streetinsider.com/Business+Wire/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- ‘HemoHim,’ an immune-boosting health supplement from <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54138541&amp;newsitemid=20241021625609&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=9b155d49752d5f05f5c309c911f60720" shape="rect">Kolmar BNH</a> (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241021625609/en/" rel="nofollow">https://www.businesswire.com/news/home/20241021625609/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241021625609/en/2278151/4/Pic._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)</p></div><p> Kolmar http://www.streetinsider.com/Business+Wire/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html Mon, 21 Oct 2024 09:00:00 -0500 200130 A.06822034 O.18769681 O.20026344 http://www.streetinsider.com/Business+Wire/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- ‘HemoHim,’ an immune-boosting health supplement from <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Fen%2F&amp;esheet=54138541&amp;newsitemid=20241021625609&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=9b155d49752d5f05f5c309c911f60720" shape="rect">Kolmar BNH</a> (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), enhancing its credibility in the global marketplace. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20241021625609/en/" rel="nofollow">https://www.businesswire.com/news/home/20241021625609/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20241021625609/en/2278151/4/Pic._HemoHim_G%2C_produced_by_Kolmar_BNH_and_distributed_by_Atomy.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Image: Kolmar BNH)</p></div><p> Kolmar http://www.streetinsider.com/Business+Wire/HemoHim+Manufacturer+Kolmar+BNH+Receives+NAI+Classification+from+the+US+FDA/23856935.html Mon, 21 Oct 2024 09:00:00 -0500 200130 A.06822034 O.18769681 O.20026344 http://www.streetinsider.com/Press+Releases/HemoHim%27s+Global+Market+Success+Rooted+in+Rigorous+Quality+Control/23636939.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- HemoHim, a health functional food developed by <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54112737&amp;newsitemid=20240823112347&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=8bb2330ef16f8988d1dd2eee6b22ee27" shape="rect">Kolmar BNH</a> (KRX: 200130), is garnering significant attention in the global market thanks to its meticulous quality control measures throughout the entire process, starting with the stringent management of raw material origins. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240823112347/en/" rel="nofollow">https://www.businesswire.com/news/home/20240823112347/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240823112347/en/2223190/4/Kolmar_0823_image.jpg" alt="HemoHim G, produced by Kolmar BNH and distributed by Atomy is gaining a great popularity around the world (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHim G, produced by Kolmar http://www.streetinsider.com/Press+Releases/HemoHim%27s+Global+Market+Success+Rooted+in+Rigorous+Quality+Control/23636939.html Fri, 23 Aug 2024 09:00:00 -0500 200130 O.18769681 http://www.streetinsider.com/Press+Releases/HemoHim%27s+Global+Market+Success+Rooted+in+Rigorous+Quality+Control/23636939.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- HemoHim, a health functional food developed by <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54112737&amp;newsitemid=20240823112347&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=8bb2330ef16f8988d1dd2eee6b22ee27" shape="rect">Kolmar BNH</a> (KRX: 200130), is garnering significant attention in the global market thanks to its meticulous quality control measures throughout the entire process, starting with the stringent management of raw material origins. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240823112347/en/" rel="nofollow">https://www.businesswire.com/news/home/20240823112347/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240823112347/en/2223190/4/Kolmar_0823_image.jpg" alt="HemoHim G, produced by Kolmar BNH and distributed by Atomy is gaining a great popularity around the world (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHim G, produced by Kolmar http://www.streetinsider.com/Press+Releases/HemoHim%27s+Global+Market+Success+Rooted+in+Rigorous+Quality+Control/23636939.html Fri, 23 Aug 2024 09:00:00 -0500 200130 O.18769681 http://www.streetinsider.com/Business+Wire/HemoHim%27s+Global+Market+Success+Rooted+in+Rigorous+Quality+Control/23636939.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- HemoHim, a health functional food developed by <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54112737&amp;newsitemid=20240823112347&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=8bb2330ef16f8988d1dd2eee6b22ee27" shape="rect">Kolmar BNH</a> (KRX: 200130), is garnering significant attention in the global market thanks to its meticulous quality control measures throughout the entire process, starting with the stringent management of raw material origins. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240823112347/en/" rel="nofollow">https://www.businesswire.com/news/home/20240823112347/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240823112347/en/2223190/4/Kolmar_0823_image.jpg" alt="HemoHim G, produced by Kolmar BNH and distributed by Atomy is gaining a great popularity around the world (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHim G, produced by Kolmar http://www.streetinsider.com/Business+Wire/HemoHim%27s+Global+Market+Success+Rooted+in+Rigorous+Quality+Control/23636939.html Fri, 23 Aug 2024 09:00:00 -0500 200130 O.18769681 http://www.streetinsider.com/Business+Wire/HemoHim%27s+Global+Market+Success+Rooted+in+Rigorous+Quality+Control/23636939.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- HemoHim, a health functional food developed by <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54112737&amp;newsitemid=20240823112347&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=8bb2330ef16f8988d1dd2eee6b22ee27" shape="rect">Kolmar BNH</a> (KRX: 200130), is garnering significant attention in the global market thanks to its meticulous quality control measures throughout the entire process, starting with the stringent management of raw material origins. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240823112347/en/" rel="nofollow">https://www.businesswire.com/news/home/20240823112347/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240823112347/en/2223190/4/Kolmar_0823_image.jpg" alt="HemoHim G, produced by Kolmar BNH and distributed by Atomy is gaining a great popularity around the world (Image: Kolmar BNH)" /><p style="font-size:85%;">HemoHim G, produced by Kolmar http://www.streetinsider.com/Business+Wire/HemoHim%27s+Global+Market+Success+Rooted+in+Rigorous+Quality+Control/23636939.html Fri, 23 Aug 2024 09:00:00 -0500 200130 O.18769681 http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54098769&amp;newsitemid=20240724688710&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=1352698bcf1a179016bd7d5399665c04" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240724688710/en/" rel="nofollow">https://www.businesswire.com/news/home/20240724688710/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240724688710/en/2194810/4/Kolmar_BNH_HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> HemoHIM G (Global) http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html Wed, 24 Jul 2024 09:00:00 -0500 200130 A.19357547 O.04673234 O.18769681 http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54098769&amp;newsitemid=20240724688710&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=1352698bcf1a179016bd7d5399665c04" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240724688710/en/" rel="nofollow">https://www.businesswire.com/news/home/20240724688710/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240724688710/en/2194810/4/Kolmar_BNH_HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> HemoHIM G (Global) http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html Wed, 24 Jul 2024 09:00:00 -0500 200130 A.19357547 O.04673234 O.18769681 http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54098769&amp;newsitemid=20240724688710&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=1352698bcf1a179016bd7d5399665c04" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240724688710/en/" rel="nofollow">https://www.businesswire.com/news/home/20240724688710/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240724688710/en/2194810/4/Kolmar_BNH_HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> HemoHIM G (Global) http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html Wed, 24 Jul 2024 09:00:00 -0500 200130 A.19357547 O.04673234 O.18769681 http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54098769&amp;newsitemid=20240724688710&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=1352698bcf1a179016bd7d5399665c04" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240724688710/en/" rel="nofollow">https://www.businesswire.com/news/home/20240724688710/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240724688710/en/2194810/4/Kolmar_BNH_HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> HemoHIM G (Global) http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html Wed, 24 Jul 2024 09:00:00 -0500 200130 A.19357547 O.04673234 O.18769681 http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54098769&amp;newsitemid=20240724688710&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=1352698bcf1a179016bd7d5399665c04" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240724688710/en/" rel="nofollow">https://www.businesswire.com/news/home/20240724688710/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240724688710/en/2194810/4/Kolmar_BNH_HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> HemoHIM G (Global) http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html Wed, 24 Jul 2024 09:00:00 -0500 200130 A.19357547 O.04673234 O.18769681 http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54098769&amp;newsitemid=20240724688710&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=1352698bcf1a179016bd7d5399665c04" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240724688710/en/" rel="nofollow">https://www.businesswire.com/news/home/20240724688710/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240724688710/en/2194810/4/Kolmar_BNH_HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> HemoHIM G (Global) http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html Wed, 24 Jul 2024 09:00:00 -0500 200130 A.19357547 O.04673234 O.18769681 http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54098769&amp;newsitemid=20240724688710&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=1352698bcf1a179016bd7d5399665c04" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240724688710/en/" rel="nofollow">https://www.businesswire.com/news/home/20240724688710/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240724688710/en/2194810/4/Kolmar_BNH_HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> HemoHIM G (Global) http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html Wed, 24 Jul 2024 09:00:00 -0500 200130 A.19357547 O.04673234 O.18769681 http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54098769&amp;newsitemid=20240724688710&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=1352698bcf1a179016bd7d5399665c04" shape="rect">Kolmar BNH</a> (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240724688710/en/" rel="nofollow">https://www.businesswire.com/news/home/20240724688710/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240724688710/en/2194810/4/Kolmar_BNH_HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)</p></div><p> HemoHIM G (Global) http://www.streetinsider.com/Business+Wire/Kolmar+BNH+Expedites+European+Market+Expansion+with+its+Technology-Driven+HemoHIM+G/23497512.html Wed, 24 Jul 2024 09:00:00 -0500 200130 A.19357547 O.04673234 O.18769681 http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Sharpens+Global+Competitiveness+with+Dual+Functionality+of+HemoHIM/23381375.html <p> SEOUL, South Korea--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fkolmarbnh.co.kr%2Feng%2F&amp;esheet=54084574&amp;newsitemid=20240620376394&amp;lan=en-US&amp;anchor=Kolmar+BNH&amp;index=1&amp;md5=b913fdefdae474ba3f52d6fd1190826f" shape="rect">Kolmar BNH</a> (KOSDAQ: 200130), a leading Original Development Manufacturing (ODM) company for health functional foods, strengthens its market position by acquiring certification for the additional functionality of HemoHIM, a renowned Korean health supplement. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20240620376394/en/" rel="nofollow">https://www.businesswire.com/news/home/20240620376394/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20240620376394/en/2166085/4/HemoHIM_G.jpg" alt="HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy, contains Angelica sinensis, Ligusticum chuanxiong, and Paeonia lactiflora. It was launched in Taiwan last month. (Photo: Kolmar BNH)" /><p style="font-size:85%;">HemoHIM G, manufactured by http://www.streetinsider.com/Press+Releases/Kolmar+BNH+Sharpens+Global+Competitiveness+with+Dual+Functionality+of+HemoHIM/23381375.html Fri, 21 Jun 2024 02:00:00 -0500 200130 O.18769681